
Expesicor receives fast-track SBIR grant from the National Institutes of Health
KALISPELL, MT, September 9, 2019 — Expesicor, a privately held, Montana-based company focused on preventing, treating, and curing neurological disorders, today announced that the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded the company $343,042 over one year for the first phase of a Small […]